Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Public ClinicalTrials.gov record NCT01576328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled Dose-Escalation Study to Assess the Safety and Tolerability of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Type 2 Diabetes Sub-optimally Controlled on Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to assess the overall safety and tolerability of a single intravenous infusion of three doses of Mesenchymal Precursor Cells versus Placebo in subjects with Type 2 Diabetes inadequately controlled on Metformin.
Study identification
- NCT ID
- NCT01576328
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2012 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Oct 2015 (Actual)
- Last update posted
- Jun 2, 2020
2012 – 2015
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SC Clinical Research | Garden Grove | California | 92844 | — |
| Diabetes Research Institute | Miami | Florida | 33136 | — |
| Compass Research | Orlando | Florida | 32806 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Tulane University Medical Center | New Orleans | Louisiana | 70112 | — |
| Big Sky Clinical Research | Butte | Montana | 59701 | — |
| Desert Endocrinology Clinical Research Center-Henderson | Henderson | Nevada | 89052 | — |
| Alliance Against Diabetes/AAD Clinical Research | Las Vegas | Nevada | 89101 | — |
| Active Practices and Research | Newington | New Hampshire | 03801 | — |
| The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Providence Health Partners - Center for Clinical Reseach | Dayton | Ohio | 45439 | — |
| Dallas Diabetes and Endocrine Center | Dallas | Texas | 75230 | — |
| West Houston Clinical Research Services | Houston | Texas | 77055 | — |
| Paragon Research Center | San Antonio | Texas | 78205 | — |
| Wasatch Clinical Research | Salt Lake City | Utah | 84107 | — |
| National Clinical Research - Norfolk, Inc | Norfolk | Virginia | 23502 | — |
| National Clinical Research - Richmond, Inc. | Richmond | Virginia | 23294 | — |
| Capital Clinical Research Center | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01576328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2020 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01576328 live on ClinicalTrials.gov.